Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HTG Molecular Diagnostics Inc HTGMQ

Healthcare Medical Devices
HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and... see more

Recent & Breaking News (GREY:HTGMQ)

30 Biggest Movers From Yesterday

Benzinga.com  December 28, 2017

Mid-Afternoon Market Update: Crude Oil Down 0.8%; Kazia Therapeutics Shares Spike Higher

Benzinga.com  December 27, 2017

Mid-Day Market Update: Energous Surges After Receiving FCC Certification For Wireless Charging; One Horizon Group Shares Drop

Benzinga.com  December 27, 2017

5 Stocks To Watch For December 27, 2017

Benzinga.com  December 27, 2017

HTG Molecular Diagnostics Expands its Collaboration with Merck KGaA, Darmstadt, Germany

GlobeNewswire December 26, 2017

HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018

GlobeNewswire December 20, 2017

HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings

GlobeNewswire November 7, 2017

HTG Molecular Diagnostics, Inc. to Host Earnings Call

Accesswire November 7, 2017

HTG Molecular Diagnostics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Tuesday, November 7

GlobeNewswire October 20, 2017

15 Biggest Mid-Day Losers For Friday

Benzinga.com  October 6, 2017

HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 25, 2017

HTG Announces Issuance of Two Method Patents Related to its Technology

GlobeNewswire September 20, 2017

HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements

GlobeNewswire September 18, 2017

Healthcare Stock Performance Review -- Glaukos, Endologix, Merit Medical Systems, and HTG Molecular Diagnostics

PR Newswire September 12, 2017

HTG Molecular Diagnostics Provides Regulatory Update for its HTG EdgeSeq ALKPlus Assay

GlobeNewswire September 11, 2017

HTG Molecular Diagnostics to Present at the Rodman & Renshaw 19th Annual Investment Conference

GlobeNewswire September 6, 2017

HTG Molecular Diagnostics’ Technology to be Used in WIN Consortium NSCLC Clinical Trial

GlobeNewswire August 9, 2017

HTG Molecular Diagnostics Reports Second Quarter 2017 Results

GlobeNewswire August 8, 2017

Investor Network: HTG Molecular Diagnostics, Inc. to Host Earnings Call

Accesswire August 8, 2017

HTG Molecular Diagnostics Announces Second Companion Diagnostic Development Project with QIAGEN

GlobeNewswire July 27, 2017